FinTech
Anteris Technologies: Launches $35m capital raise as FDA approves DurAVR study
Anteris Technologies Launches $35m capital raise as FDA approves DurAVR studyAnteris Technologies (AVR) launches a $35 million capital raise for the clinical development...
FinTech
Anteris Technologies: Reports positive data from first-in-human heart valve trial
Anteris Technologies Reports positive data from first-in-human heart valve trialMeditech specialist Anteris Technologies (ARV) reports “excellent” results from the first-in-human trial of its...
FinTech
Anteris Technologies: Raises cash to develop 3D heart value
Meditech Anteris Technologies (AVR) has raised $1.1 million via a placement to help fuel its work developing a 3D heart valve
Anteris raised...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
